Jeffrey Charpentier

Sierra Wireless, Inc. engages in the provision of device-to-cloud and networking solutions. It operates through the Embedded Broadband and Internet-of-Things Solutions (IoT) segments. The Embedded Broadband segment is consists cellular embedded modules that are typically used in non-industrial applications, namely Automobile, Mobile Computing and Enterprise Networking markets. The IoT segment offers end-to-end IoT solutions that include recurring connectivity services, cloud management software, and cellular modules and gateways.The company was founded on May 31, 1993 and is headquartered in Richmond, Canada.

Inex Pharmaceuticals Corporation is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer.

Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology

Lifebank Corp. is a cryogenic facility company engages in the business of processing and cryopreserving umbilical cord blood stem cells for families. It offers clinically proven procedures available for the cryogenic storage of umbilical cord blood stem cells. It uses umbilical cord stem cells for the treatment of diseases, such as leukemia, metabolic disorders, immune disorders, bone marrow failure, genetic disorders, and many others. Lifebank markets its services by using various avenues including distributing brochures to doctors' offices, clinics and hospitals, delivering lectures to groups of doctors and other healthcare providers, speaking at prenatal classes, and maintaining contact with the media to encourage informed articles about umbilical cord blood stem cells. The company was founded on Feb 21, 1996 and is headquartered in Burnaby, Canada.

Lignol Energy Corp. engages in the development of biorefining technologies for the production of biofuels, biochemicals, and biomaterials from non-food biomass feedstocks and waste biomass. The firm also owns cellulosic ethanol technology. The company was founded on September 14, 1964 and is headquartered in Burnaby, Canada.

viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada.